1. Home
  2. TCI vs EBS Comparison

TCI vs EBS Comparison

Compare TCI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

N/A

Current Price

$35.43

Market Cap

343.6M

Sector

Finance

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.18

Market Cap

409.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
EBS
Founded
1983
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
343.6M
409.5M
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
TCI
EBS
Price
$35.43
$8.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
3.1K
726.1K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
135.29
125.83
EPS
1.60
0.93
Revenue
$49,060,000.00
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
$22.10
$8.85
Revenue Growth
4.23
N/A
52 Week Low
$26.96
$4.02
52 Week High
$59.65
$14.06

Technical Indicators

Market Signals
Indicator
TCI
EBS
Relative Strength Index (RSI) 45.48 39.85
Support Level $31.48 $7.83
Resistance Level $47.17 $9.28
Average True Range (ATR) 1.54 0.27
MACD 0.65 0.13
Stochastic Oscillator 50.11 44.93

Price Performance

Historical Comparison
TCI
EBS

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: